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Objectives. This study examined the associations of left ventric- 
ular mass with self-reported cocaine and alcohol use prevalent in 
the young adult population. 
Background. Increased left ventricular mass has been associ- 
ated with long-term use of cocaine and alcohol; however, few of the 
published studies have been population based. 
Methods. Data from 3,446 black and white participants (mean 
age 29.9 years) in the Coronary Artery Risk Development in 
Young Adults (CARDIA) study were used to examine the associ- 
ations between echocardiographically measured left ventricular 
mass obtained from 1990 to 1991 and self-reported cocaine and 
alcohol use. Categories of cocaine use were those who denied ever 
using cocaine (n = 2,122), experimental users who admitted to 
cocaine use only 1 to 10 times in their lifetime (n = 755) and 
recurrent users who admitted to cocaine use >10 times in their 
lifetime (n = 568). For alcohol consumption, categories were 
abstainers who consistently denied any alcohol consumption in 
the year before ach of the three CARDIA examinations (n = 275), 
occasional users who admitted consuming alcohol ess than once 
a week or not at all during the year before the third examination 
(n = 1,322), moderate users who consumed 1 to 209 ml of 
alcohol/week during the year before the third examination (n = 
1,524) and heavy users who consumed >210 ml of alcohol/week 
during the year before the third examination (  = 323). Estimated 
power to detect a 10% difference in left ventricular mass between 
groups was >80%. 
Results. For white women, left ventricular mass was signifi- 
cantly higher among those who reported 1 to 10 lifetime uses of 
cocaine than in never-users (128.5 g [SE 2.0] vs. 122.7 g [SE 1.4], 
p = 0.002). There were no other significant di~erences in left 
ventricular mass among categories of cocaine or alcohol use in 
unadjusted analyses or among analyses controlling for age, body 
mass index, alcohol or cocaine use, physical activity, cigarette 
smoking status and systolic blood pressure. 
Conclusions. At the levels of consumption reported, neither 
cocaine nor alcohol use was associated with left ventricular mass 
in this cohort of healthy oung adults. 
(J Am Coll Cardiol 1995;25:895-900) 
Increased left ventricular mass as measured by echocardiogra- 
phy precedes the clinical presentation of some forms of cardiac 
disease (i.e., congestive heart failure, hypertensive cardiomy- 
opathy) (1-5) and is itself a risk factor for cardiovascular 
mortality (5,6). Several recent studies (7-11) have reported an 
association of left ventricular mass with long-term use of either 
cocaine or alcohol. Increased left ventricular mass has been 
reported among long-term male cocaine abusers admitted to a 
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Veterans Affairs hospital for treatment of cocaine addiction 
compared with age-matched male nonusers (7). Studies of 
alcoholic subjects (8-11) and Framingham study participants 
(12) have also shown associations of alcohol intake with left 
ventricular mass. 
However, interpretation of much of the available data is 
limited because of small sample sizes, lack of appropriate control 
subjects and failure to adjust for tobacco consumption and other 
confounders. Furthermore, few studies have examined these 
associations in general population samples, where use patterns 
differ markedly from samples of patients eeking treatment for 
abuse or for medical consequences of substance use. Finally, 
there have been few studies examining associations of left ven- 
tricular mass with use of cocaine or alcohol in women and blacks. 
Thus, we examined the associations of left ventricular mass with 
self-reported cocaine and alcohol use in a large, well described, 
longitudinal population-based sample to determine the relevance 
of prevalent cocaine and alcohol use to left ventricular mass in the 
young adult population. 
© 1995 by the American College of Cardiology 0735-1097/95/$9.50 
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Methods 
Study population. The Coronary Artery Risk Develop- 
ment in Young Adults (CARDIA) study is a prospective 
epidemiologic study designed to determine the antecedents of 
cardiovascular disease risk factors in young adults and to 
identify health habits and behaviors that predict he levels of, 
and changes in, these risk factors. During 1985 and 1986, 5,115 
young adults 18 to 30 years old were recruited from four cities: 
Birmingham, Alabama; Chicago, Illinois; Minneapolis, Minne- 
sota; and Oakland, California. The study population was 
approximately balanced at baseline according to age (18 to 24 
and 25 to 30 years), gender, race (black and white) and 
educational level (high school graduate or less and beyond 
high school). Details of the study design and participant 
characteristics atbaseline have been described elsewhere (13). 
The study was approved by the institutional review committee 
of each center; examination procedures followed established 
human use guidelines. Participants gave written informed 
consent at each examination. 
Ninety-one percent of the surviving participants returned 
during 1987 to 1988 for a second examination, and 86% 
returned for a third examination during 1990 to 1991, when 
echocardiography was performed. Retention rates for the third 
examination were similar for various categories of alcohol or 
cocaine use: 89% of those who admitted to consuming 
>210 ml of alcohol/week at the second examination returned 
for the third examination, compared with 88% of alcohol 
abstainers; 91% of those who admitted to >10 lifetime uses of 
cocaine at the second examination returned for the third 
examination, compared with 89% of those who denied ever 
using cocaine. 
The study sample included 3,446 of the 4,352 participants 
attending both the second and third examinations. We ex- 
cluded from analyses 238 participants who had missing drug 
use data at the second examination, 34 who had missing drug 
use data at the third examination, 180 who had missing left 
ventricular mass data and 277 who had inconsistent drug use 
data (participants reporting any drug use at the second exam- 
ination who denied ever having used drugs at the third 
examination). 
Data collection. Drug and alcohol use. Self-administered 
questionnaires given at both the second and third examinations 
were used to determine whether aparticipant had ever used a 
variety of illicit drugs (marijuana, cocaine, opiates or amphet- 
amines). Follow-up questions quantified use of each drug over 
the participant's lifetime and use within the previous 30 days. 
As described previously (14), alcohol consumption was deter- 
mined at each examination by an interviewer-administered 
questionnaire that quantified the number of drinks consumed 
per week of wine (5 oz [148 ml]), beer (12 oz [355 ml D and 
liquor (1.5 oz [44 ml]). The total milliliters of absolute alcohol 
consumed per week was calculated as follows: [(Wine × 
17.02) + (Beer × 16.7) + (Hard liquor x 19.09)]. 
Echocardiography. The echocardiographic protocol used in 
the CARDIA study was very similar to that previously de- 
scribed for the Cardiovascular Health Study (15). M-mode and 
two-dimensional echocardiograms were obtained with patients 
lying in the left lateral decubitus position using a 2.5-MHz 
Acuson phased-array sector scanner. Stop-frame M-mode and 
real-time two-dimensional images were recorded at 30 
frames/s on 0.5-in. super-VHS tape and sent to the central 
Echocardiography Reading Center, University of California- 
Irvine. For each participant, he two-dimensional parasternal 
long-axis view, parasternal short-axis view at the level of the 
papillary muscle tips and the apical four and two-chamber- 
views were obtained. M-mode images of the left ventricle were 
recorded using two-dimensional parasternal images to direct 
the M-mode cursor perpendicular to the ventricular septum 
and left ventricular posterior wall at approximately the level of 
the mitral leaflet tips. All recordings were performed with 
respiration suspended atmidexpiration. 
Measurements were made from digitized images using a 
Dextra D-200 off-line image analysis system. Images were 
played back on a super-VHS videotape recorder and digitized 
at 30 frames/s in real time. All measurements were traced on a 
video screen using a digitizer, with primary measurement data 
going directly into a dBase IV data base (Ashton-Tate). 
Quality control measures for echocardiography included stan- 
dardized training of echocardiographic technicians and read- 
ers, technician observation by a trained echocardiographer, 
blind duplicate readings to establish intrareader (4% sample) 
and interreader (8% sample) measurement variability, peri- 
odic review sessions, phantom studies on the ultrasound equip- 
ment and quality control audits. 
M-mode left ventricular mass was calculated from the for- 
mula of Devereux et al. (16) with the correction factor for 
measurements performed using the following American Soci- 
ety of Echocardiography convention (17): Left ventricular 
mass (g) = 0.08 {1.04[(VSTd + LVIDd + PWTd) 3 - 
(LVIDd)3]} + 0.6, where VSTd = ventricular septal thickness 
at end-diastole (cm); LVIDd = left ventricular internal dimen- 
sion at end-diastole (cm); and PWTd = left ventricular poste- 
rior wall thickness at end-diastole (cm). Left ventricular inter- 
nal dimension at end-systole (cm) was also determined from 
M-mode images. Average values from 3 beats were used in 
analyses; measurements were made on a stop-frame super- 
VHS image from cycles in which the right and left side of the 
ventricular septum, and the endocardial nd the epicardial 
interfaces of the left ventricular posterior wall, were clearly 
defined. 
Other factors. Potential confounding factors included age, 
race, gender, height, body mass index, physical activity, ciga- 
rette smoking and blood pressure. Body weight was measured 
in light clothing to the nearest 0.5 lb (0.227 kg) with a 
calibrated balance-beam scale; height (without shoes) was 
measured to the nearest 0.5 cm using a vertical ruler. Body 
mass index was computed as follows: [Weight (lb)/2.2]/[Height 
(cm)/100] 2.Physical activity was assessed using the reported 
frequency of participation i  each of 13 physical activities 
during the previous year, weighted by the intensity level of 
each activity, and then summed to give a total physical activity 
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score (18). Self-reported measures of cigarette smoking 
(present, past and never) (19), age at the third examination, 
race and gender were also used in analyses. Three sitting blood 
pressure measurements were obtained, after a 5-min rest and 
at l-rain intervals from the right arm of all participants; the 
average of the second and third measurements was used in 
analyses. Trained and certified technicians used a Hawksley 
random-zero sphygmomanometer (W. A. Baums Co.) and 
common protocols for blood pressure measurements. 
Statistical analysis. Three categories were created to eval- 
uate cocaine use at the third examination on the basis of the 
participants' report of any lifetime use of cocaine. These 
categories divided the cohort (n = 3,446) into those who 
denied ever using cocaine (n = 2,122), experimental users who 
admitted to cocaine use only 1 to 10 times in their lifetime (n = 
755) and recurrent users who admitted to cocaine use >10 
times in their lifetime (n = 568). The latter category included 
participants reporting 11 to 99 lifetime uses and ->100 uses, 
which were combined because of small numbers in the highest 
category. Because only 94 participants admitted using cocaine 
within 30 days of their third CARDIA examination, stratifica- 
tion for this use pattern was not done because of small 
numbers in the race-gender g oups. Cocaine use could not be 
further separated from use of other illicit drugs because only 
two participants admitted exclusive use of cocaine. The small 
number of participants (n = 9) who admitted to use of other 
illicit drugs (i.e., opiates or amphetamines) in the absence of 
marijuana or cocaine use precluded separate analyses of these 
groups. 
We created categories to evaluate alcohol use in partici- 
pants for whom data were available on alcohol consumption 
(n = 3,129); categories were based on the findings of an 
association between alcohol intake and left ventricular mass in 
Framingham subjects (12). We defined abstainers as partici- 
pants who consistently denied any alcohol consumption (i.e., 
those who denied any use in the year before ach of their three 
CARDIA examinations [n = 275]). Definitions of the other 
categories were based on current use (i.e., that reported uring 
the year before the third examination). Occasional users 
admitted consuming alcohol less than once a week or not at all 
during the year before the third examination (n = 1,322); 
moderate users admitted consuming 1 to 209 ml of alcohol/ 
week during this period (n = 1,524); and heavy users admitted 
consuming ->210 ml of alcohol/week (n = 323). To examine 
the effects of larger intakes of alcohol and the stability of 
findings at different levels, we also examined associations for 
those consuming 1to 350 ml of alcohol/week (n = 1,705) and 
those consuming >350 ml of alcohol/week (n = 142); however, 
because the results were similar, these data are not presented. 
We excluded from analyses 177 participants who were 
known to be hypertensive (self-reported history of antihyper- 
tensive drug use or systolic blood pressure >140 mm Hg or 
diastolic blood pressure >90 mm Hg at examination). How- 
ever, data that included participants with hypertensive blood 
pressure levels who were not taking antihypertensive m dica- 
tion yielded similar results to those reported here. 
Associations of left ventricular mass and baseline charac- 
teristics of potential confounders were examined between 
race-gender g oups using analysis of variance and chi-square 
tests where appropriate. Pairwise comparisons were tested 
using the Scheff6 procedure (20). Associations of unadjusted 
left ventricular mass with cocaine and alcohol use were exam- 
ined with trend tests within the race-gender groups (21). 
Analysis of covariance was also used to examine associations of 
left ventricular mass with cocaine and alcohol use for the 
race-gender g oups, controlling for significantly confounding 
factors, including systolic blood pressure, age, physical activity, 
smoking status and alcohol or cocaine consumption. Analyses 
were repeated, controlling for number of cigarettes smoked 
per day (0 for nonsmokers and for ex-smokers) instead of 
smoking status; these findings are not presented because of 
similar results. Separate models were used to control for body 
mass index and height. The experimental error rate of alpha 
0.05 was adjusted with a Bonferonni correction, depending on 
the number of comparisons made (20). Analyses were per- 
formed with SAS version 6.04 software. 
Results 
Because of the initial eligibility criteria, the sample was 
young (mean age 29.9 years), had higher than a high school 
education on average and had approximately equal represen- 
tation from black and white, as well as male and female, groups 
(Table 1). Left ventricular mass was significantly greater in 
men than in women and in blacks than in whites. There were 
also significant race- or gender-related differences, or both, in 
cocaine and alcohol use and in demographic and other char- 
acteristics of the participants. Although >50% of the partici- 
pants denied ever having smoked tobacco or used cocaine, 
<10% of the cohort consistently reported that they abstained 
from alcohol use at each of the three examinations. 
Left ventricular mass was not consistently associated with 
either increased cocaine (Table 2) or alcohol use (Table 3) 
when compared with that of nonusers of these substances. In 
unadjusted analyses, cocaine was associated with left ventric- 
ular mass only among white women; however, a clear dose- 
response association was not present in pairwise comparisons 
(Table 2). No significant associations with alcohol were present 
(Table 3). When the data were adjusted for height as well as 
other potential confounders (systolic blood pressure, age, 
physical activity, smoking status, alcohol or cocaine consump- 
tion), there were again no associations of either cocaine or 
alcohol use with left ventricular mass within race-gender 
groups (data not shown). In models adjusted for the other 
potential confounders and body mass index, the only signifi- 
cant difference found was in white women who reported 1to 10 
lifetime uses of cocaine compared with those who reported 
never having used cocaine (129.5 g [SE 1.9] vs. 121.9 g [SE 1.4], 
respectively, p = 0.002). Further analyses by type of alcoholic 
beverage (beer, wine or liquor) within race-gender groups 
revealed no association between left ventricular mass and 
alcohol consumption. 
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Table 1. Characteristics of 3,446 Participants: CARDIA Study, 1990 to 1991 
Men Women 
Black White Black White 
Age (yr) 29.3 (3.7)* 30.5 (3.4)* 29.3 (3.9)* 30.5 (3.5)* 
Education (yr) 13.5 (2.1)* 15.3 (2.6)* 13.7 (1.9)* 15.3 (2.4)* 
Systolic BP (ram Hg) 112 (9.4)*,1, 109 (9.5)*t 105.4 (9.3)*t 101 (8.6)*t 
Diastolic BP (ram Hg) 72 (8.5)*,1, 70 (8.3)*+ 68 (8.7)*t 65 (8.1)*,1, 
Body mass index (kg/m:) 26.4 (5.0)*,1, 25.3 (3.8)*+ 27.8 (7.2)*t 24.2 (4.8)*,1, 
Physical activity, score 488.7 (347.7)t 465.9 (289.9),1, 261.8 (227.5)*i 345.0 (247.7)*,1, 
LVM (g) 174.3 (42.6)*t 168.7 (39.5)*,1, 132.2 (34.9)*t 125.1 (33.1)*,1, 
Never smoked tobacco (%) 56t 61 64",1, 58* 
Never used cocaine (%) 63't 50,1,* 77',1, 56*+ 
Alcohol abstainers (%) 10" 5* 13' 6* 
*p < 0.0125, race comparison within gender (black men vs. white men, black women vs. white women), tp < 0.0125, 
gender comparison within race (black men vs. black women, white men vs. white women), Bonferroni correction 0.05/4 -
0.0125. Data presented are mean value (SD), unless otherwise indicated. BP - blood pressure; LVM = left ventricular 
mass.  
Echocardiographic measures of left ventricular internal di- 
mension at end-diastole and end-systole, ventricular septal 
thickness at end-diastole and left ventricular posterior wall 
thickness at end-diastole were also not significantly associated 
with cocaine or alcohol use (data not shown). 
D iscuss ion  
Our data do not support associations of cocaine or alcohol 
use with left ventricular mass at the levels of consumption 
reported in this healthy population of black and white young 
men and women. The isolated, statistically significant associa- 
tion of left ventricular mass with cocaine use in white women 
did not show a monotonic dose-response r lation (22) and was 
small and inconsistent with the findings in the other race- 
gender groups. Thus, this finding is unlikely to be of clinical 
significance, 
Table 2. Unadjusted Left Ventricular Mass (g) by Lifetime Cocaine 
Use: CARDIA Study, 1990 to 1991 
Men Women 
Black White Black White 
(n = 662) (n = 862) (n 923) (n = 998) 
Never used cocaine 
No. 417 433 712 560 
Mean (SE) 173.6 (2.1) 167.7 (1.9) 131.6 (1.3) 122.7 (1.4) 
1-10 uses of 
cocaine 
No. 119 235 132 269 
Mean (SE) 174.4 (3.9) 168.8 (2.6) 132.8 (3.0) 128.5 (2.0)* 
>10 uses of cocaine 
No. 126 194 79 169 
Mean (SE) 176.5 (3.8) 170.8 (2.8) 136.8 (3.9) 127.3 (2.5) 
Overall p value? 0.80 0.67 0.45 0.04 
p value trend 0.51 0.22 0.38 0.04 
*p < 0.025, comparisons within race-gender groups, using never-used 
cocaine as reference group; Bonferroni correction 0.05/2 = 0.025. ?Analysis of 
variance. 
Previous studies of cocaine and left ventricular mass. Our 
results differed from those of others, who have reported 
associations of cocaine with left ventricular mass. Brickner et 
al. (7) reported that alcohol consumption >210 ml/week and 
cocaine abuse were independently associated with left ventric- 
ular mass index and posterior wall thickness in men undergo- 
ing inpatient treatment for cocaine abuse compared with 
hospital house staff and employees matched for race and age 
who denied illicit drug use. However, interpretation of these 
data is limited because of failure to adjust for tobacco con- 
sumption, small sample size, use of a control sample that 
differed from the study sample on many characteristics besides 
cocaine use and lack of female patients. In addition, the level 
and duration of use of cocaine or other substances may have 
been substantially different from that typical of CARDIA 
Table 3. Unadjusted Left Ventricular Mass (g) by Alcohol 
Consumption: CARDIA Study, 1990 to 1991 
Men Women 
Black White Black White 
(n = 661) (n - 862) (n 924) (n = 997) 
Alcohol abstainers* 
No. 63 40 117 55 
Mean (SE) 173.4 (5.4) 172.6 (6.2) 131.1 (3.2) 122.9 (4.5) 
Alcohol use more than 
once a wk 
No. 196 207 480 439 
Mean (SE) 174.4 (3.0) 167.8 (2.7) 131.4 (1.6) 126.6 (1.6) 
1-209 ml alcohol/wk 
No. 276 492 290 466 
Mean (SE) 174.8 (2.6) 167.3 (1.8) 132.8 (2.0) 123.4 (1.5) 
->210 ml alcohol/wk 
No. 126 123 37 37 
Mean (SE) 173.1 (3.8) 174.5 (3.6) 141.0 (5.7) 129.2 (5.4) 
Overall p value+ 0.98 0.28 0.42 0.40 
p value trend 0.94 0.48 0.21 0.64 
*p < 0.017, comparisons within race-gender groups, using alcohol abstainers 
as reference group; Bonferroni correction 0.05/3 = 0.017. ?Analysis of variance. 
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participants. In a similar study of 52 male veterans eeking 
treatment for crack cocaine addiction, Chakko et al. (23) 
reported that 54% were found to have left ventricular hyper- 
trophy by echocardiography, whereas none of the normal 
volunteers and psychiatric ontrol patients tudied had this 
finding. Measures of left ventricular mass were also signifi- 
cantly higher in the abusers than in the control groups. 
Limitations of that study were that race was not balanced 
across groups (there were many more blacks in the crack users 
than in the other groups) and although Chakko et al. stated 
that tobacco and alcohol use was similar between crack users 
and psychiatric controls, these factors were not controlled for 
in the analyses. Finally, the groups were somewhat older on 
average (36 years for crack users to 33 years for normal control 
subjects) than those in the CARDIA cohort. Numerous other 
investigators (24-32) have reported cocaine-associated cardio- 
vascular effects in addition to increased left ventricular mass. 
Interpretation of the associations in these retrospective 
studies is complicated by many factors, including 1) current 
and previous polysubstance use (i.e., alcohol, tobacco and 
other drugs) (24-26,29,30,33,34); 2  pattern of cocaine use 
(long term, intermittent or short term) (25,26,30,35-37); 
3) method of cocaine administration (i tranasal, inhalation or 
injection) (25,26,31,35-37); 4) life-style associated with illicit 
drug use (crime, violence, trauma nd stress) (30,34-36); and 
5) sample bias (35-38). 
Previous studies of alcohol and left ventricular mass. 
Other recent studies have addressed the relation between 
alcohol consumption and left ventricular mass (8-12). In 4,491 
Framingham Study participants (mean age >50 years) who 
were free of apparent cardiovascular disease at baseline, left 
ventricular mass was independently associated with total alco- 
hol intake in men but not in women (12). The gender 
difference was solely attributed to the inverse association of 
liquor (as opposed to beer and wine) with left ventricular mass 
in women. That study did not address the effect of alcohol 
consumption on left ventricular mass in younger adults, which 
is the age group with the highest prevalence ofheavy drinking 
(39,40). Several other studies of alcoholic subjects (8-11) have 
also reported an association of alcohol with increased left 
ventricular mass; however, it is very difficult o interpret these 
findings because of the small sample sizes involved and lack of 
control for confounders. 
Study limitations. Although we report no association be- 
tween cocaine or alcohol use and left ventricular mass, extrap- 
olation of our data to other populations hould be done 
cautiously because of several imitations of this study, First, 
although the CARDIA study is a large population-based 
sample, the sample sizes of the highest use categories were 
relatively small. The relatively low prevalence ofheavy cocaine 
or alcohol use in our sample may have limited our power to 
detect associations of left ventricular mass with use of these 
substances. However, we estimate that our power to detect a 
10% difference in left ventricular mass between use groups was 
>80% in all groups and was frequently >90%. Furthermore, 
the level of use in our study may be more reflective of that in 
the general population and thus may better indicate the risk of 
increased left ventricular mass attributable to cocaine and 
alcohol in the general population. Second, the criteria that we 
selected may be too inclusive for both alcohol and cocaine. Our 
operational definition of recurrent cocaine use included par- 
ticipants who admitted to use on at least 11 occasions in their 
lifetime. Most of these recurrent users denied use of cocaine 
within the 30 days before their CARDIA examination and may 
not have used cocaine for years. Although we were able to 
define alcohol consumption i  terms of average weekly intake 
in the year preceding the third examination, we were not able 
to quantify duration of alcohol consumption at those levels. 
Undoubtedly, not all of the CARDIA cohort classified as 
heavy users were long-term alcohol abusers. Finally, cardiovas- 
cular sequelae, such as increased left ventricular mass, may be 
dependent on both quantity of cocaine or alcohol consumed 
and duration of heavy use. Because our study sample was 
young, cocaine and alcohol use probably did not extend beyond 
a decade or two. It is thus possible that cardiovascular effects 
of continued long-term cocaine or alcohol consumption, or 
both, in the CARDIA cohort might be demonstrable after 
more sustained use. 
Prevalence of substance use. A further limitation of this 
study is that our categorization f alcohol and cocaine use was 
based solely on self-report. Furthermore, the generalizability 
of our findings could be affected by differences insubstance use 
patterns between CARDIA participants and other young 
urban adults. We therefore compared alcohol and drug use 
characteristics in the CARDIA study with those of other 
samples to determine any differences in drug-use history. The 
self-reported prevalence of abstinence, xperimentation a d 
recurrent use of cocaine and alcohol in the CARDIA study is 
similar to that found in other population-based surveys, such as 
the Behavioral Risk Factor Surveillance Study (40) and the 
National Household Survey (39). In specific analyses, the 
lifetime use of alcohol in CARDIA participants was compara- 
ble to that of similarly aged respondents o the National 
Household Survey on Drug Abuse (39). Lifetime use of 
cocaine was higher in CARDIA participants; however, the 
proportion of heavier cocaine use was similar. In the CARDIA 
study, 43% of participants who admitted to ever using cocaine 
reported using cocaine on >10 occasions in their lifetime 
compared with 41% of 26 to 34-year old respondents inter- 
viewed in the 1990 National Household Survey on Drug Abuse 
(39). In contrast to the National Household Survey, CARDIA 
participants were recruited from large metropolitan areas 
where a higher prevalence ofillicit drug use is found compared 
with areas with a lower population density (39). The preva- 
lence of illicit drug use found in the longitudinal Harlem 
Health Study was similar to that in the CARDIA study; in the 
Harlem study 46% of 26 to 31-year old respondents (n = 411) 
reported "nonexperimental" lifetime cocaine use, and 96% 
any lifetime alcohol use (41). Thus, although underreporting of 
cocaine or alcohol use, or both, by participants could poten- 
tially have biased our results toward the null, the generally 
consistent reporting between the second and third examina- 
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tions by participants and the similar prevalence ofuse between 
CARDIA and other population-based studies makes this un- 
likely. 
Conclusions. We found no consistent associations of left 
ventricular mass with the levels of cocaine or alcohol use 
reported by this group of healthy oung adults. However, we 
cannot conclude that alcohol and cocaine are not risk factors 
for the development of cardiovascular complications if used 
over longer periods of time or at different levels of consump- 
tion than reported by CARDIA participants. Further esearch 
is needed to determine whether exposure thresholds exist for 
these substances. However, the pattern of use prevalent in this 
sample was not associated with left ventricular mass and 
implies that cocaine and alcohol use may not be important 
determinants of left ventricular mass in the young adult 
population overall. 
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